Piper Jaffray Expands Biotechnology Investment Banking Team With Addition Of Chris Collins
6/18/2014 11:37:55 AM
Piper Jaffray (NYSE:PJC), a leading investment bank and asset management firm, today announced that Chris Collins has joined the firm as a principal in its biotechnology investment banking group. His experience includes more than 14 years in financial services including 12 years focused on the biotechnology industry. He will be based in the firm’s San Francisco office.
Help employers find you! Check out all the jobs and post your resume.
comments powered by